Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

170.16 -2.83 (-1.64%)
Official Closing Price Updated: 7:00 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,364,395
Open 173.47
Bid (Size) 169.90 (2)
Ask (Size) 170.40 (1)
Prev. Close 172.99
Today's Range 168.54 - 174.17
52wk Range 153.58 - 218.66
Shares Outstanding N/A
Dividend Yield 3.86%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is the Market Bullish or Bearish on AbbVie?
Via Benzinga
Is AbbVie Stock a Buy?
The pharmaceutical giant has been a roller coaster over the past several months. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
Exposures Intellectual Property Political Tariff

Performance

YTD
-5.2%
-5.2%
1 Month
-19.0%
-19.0%
3 Month
-1.4%
-1.4%
6 Month
-8.8%
-8.8%
1 Year
+1.4%
+1.4%

More News

Read More
A Congress Member Sold Up To $120K In AbbVie Stock: Here's What You Need To Know
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Via Benzinga
Topics Government
Exposures Political
AbbVie Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
AbbVie Unusual Options Activity
Via Benzinga
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
34-Year-Old Making $3,400 a Month in Dividends Shares His Top 7 Stocks — 'Be Lucky and Save Relentlessly'
Via Benzinga
After The Tariff Flush, A Fresh Look At AbbVie Pharma
Via Talk Markets
Topics Stocks / Equities
Meta, TJX, Taiwan Semiconductor Manufacturing And A Health Care Stock: CNBC's 'Final Trades'
Via Benzinga
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
Via Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
3 Biopharmaceutical Stocks Bucking the Sell-Off
Via MarketBeat
Topics World Trade
Exposures Product Safety Tariff
The Last Time the Stock Market Started a Year This Badly Was 2022. Is Another Crash Coming?
Via The Motley Fool
Topics Economy Government World Trade
Exposures Economy Interest Rates Political
What's going on in today's session: S&P500 movers
Via Chartmill
These S&P500 stocks are gapping in today's session
Via Chartmill
Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday?
Via Benzinga
Topics World Trade
Exposures Tariff
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via Chartmill
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Elliott Wave Technical Analysis: AbbVie Inc. - Wednesday, April 9
Via Talk Markets
Topics Stocks / Equities
2 Top Dividend Stocks That Could Set You Up for Life
Via The Motley Fool
Topics Government Initial Public Offering Intellectual Property
Exposures Intellectual Property Political Securities Market
Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
Via The Motley Fool
Topics Government
Exposures Political
3 Dividend Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
Topics Economy Intellectual Property
Exposures Economy Intellectual Property

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 170.16
When was AbbVie last traded?
The last trade of AbbVie was at 04/21/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.